Bioniche

Check latest stock price

All prices delayed at least 15 minutes.
Source: TSX Inc.

December 18, 2007 — 11:30am ET

Watch Webcast

July 10, 2008
Bioniche Presents E. coli O157:H7 Vaccine Data to World Buiatrics Congress in Budapest, Hungary">

What do you know about bladder cancer? It is the 4th most common cancer in men and the 8th most common cancer in women.

Helping endangered species survive Assisted Reproductive Techniques (ART) Help Endangered Species Survival
There are approximately 110 Australian animal species classified as endangered, meaning they are likely to become extinct unless the various threats and pressures affecting them are removed.


		An interview with Dr. Francois Charette, Chief Medical Officer at Bioniche Life Sciences Inc.				An interview with Dr. Nigel C. Phillips, Chief Scientific Officer at Bioniche Life Sciences Inc.

Bioniche Life Sciences is the commercialization partner in the world’s first food safety vaccine: a cattle vaccine against E. coli O157:H7. The Company is scaling up production of the vaccine in order to ensure sufficient supply to meet Canadian demand following authorization from the Canadian Food Inspection Agency (CFIA) to distribute the vaccine to Canadian veterinarians.

Canada's Top 10 Life Science Companies Competition Winner

Web system design by: